Eloha Vol 3

• Description

Eloha Vol 3 is the first hyaluronic acid- (HA)-based filler with a hybrid mono- and biphasic structure. The ratio of mono- and biphasic HA in Eloha Vol 3 is 3 to 7. Due to the special patented R Square technology, Eloha fillers have a unique multilayer structure: the HA gel presents biphasic HA particles inside of monophasic HA particles. Such a structure allows achieving excellent aesthetic results due to the even distribution of the filler in dermal layers and a natural-looking effect. Smooth and ease injection of the Eloha Vol 3 filler, as well as the presence of lidocaine in the composition, makes the procedure painless and comfortable.

Strengths of Eloha:

• the first HA filler with a hybrid biphasic-monophasic structure
• long-lasting and natural-looking esthetic effect due to the special “R Square” technology
• no filler migration to adjacent tissues
• the Eloha series contains three products varying in the ratio of monophasic to biphasic HA depending on the scope of use
• minimized risk of post-injection edema and bruises

Eloha Vol 3 is ideal for face contouring and volumization. The filler is used for deep and ultra-deep injection (subcutaneous and supraperiosteal augmentation).

Scope of Eloha Vol 3:

• lip augmentation
• jawline and chin correction
• facial volumization (forehead, temples, chin, preauricular and cheekbone areas)
• nose bridge/ridge improvement

The aesthetic effect lasts from 12 to 15 months.

Product composition: HA 20 mg/ml, Lidocaine 0.3%

Eloha Vol 3

1 syringe × 1.0 ml, 2 needles per pack

Needle size: 25G, 27G

Manufacturer: Daewoong Co., Ltd., South Korea

The product has contraindications. We are not responsible for any negative effects that you may encounter after administering products by yourself. Consulting a doctor or medical professional is recommended prior to any procedure.